BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 30.70
-1.35 (-4.21%)
Oct 22, 2026, 4:00 PM EDT
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 13.36 billion as of October 22, 2026. It is the 6,546th most valuable company in the world and the 1,150th biggest in China. Its market cap has decreased by 39.51% in one year.
Market Cap
13.36B
Enterprise Value
15.00B
Revenue
1.36B
Global Rank
Country Rank
#1,150 China
PE Ratio
132.38
ChartMarket Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 13.36B, an increase of 6.47%. That is a compound annual growth rate of 0.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 13.36B | -35.57% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acrobiosystems | 16.34B |
| Sinocelltech Group | 16.00B |
| HitGen | 15.10B |
| Jinyu Bio-technology | 13.82B |
| Sino Biological,Inc. | 13.73B |
| Anhui Anke Biotechnology (Group) | 13.52B |
| GemPharmatech | 12.38B |
| Nanjing Vazyme Biotech | 11.58B |